In the ever-evolving landscape of medical histopathology, the quest for efficiency, standardization, and cost-effectiveness has driven groundbreaking innovations. At the forefront of this revolution is the BxChip® technology by Lumea,…
Lumea Inc., a leader in integrated digital pathology solutions, is pleased to announce our partnership with Invitae Corporation (Invitae), a leading medical genetics company. This partnership will give Lumea diagnostic…
Lumea Inc., a pioneer in global integrated digital pathology solutions, is thrilled to announce the second annual Digital Diagnostic Summit. This groundbreaking event will take place in the picturesque surroundings…
LEHI, UT, May 16, 2023—Lumea, a leader in integrated digital pathology solutions, is pleased to announce that Acupath is partnering with Lumea to adopt the Lumea Viewer+™, leveraging its modular…
At the medical center of the University of Medicine and Pharmacy in Ho Chi Minh City, patients are not screened for bladder cancer using urine cytology because the pathology department…
LEHI, UTAH, UNITED STATES, October 27, 2022 – Lumea is pleased to announce the launch of its gastrointestinal (GI) digital pathology platform with Granite Peaks. Granite Peaks is the first…
*BxLink has not been approved by the FDA for digital primary diagnosis. Refer to CAP guidelines regarding the use of digital pathology technologies.
